Publication | Closed Access

Cell-specific gene therapy driven by an optimized hypoxia-regulated vector reduces choroidal neovascularization

Regenerative MedicineCell TherapyAngiogenesisMedicineVascular AdaptationVascular BiologyBiomedical EngineeringNeovascularizationCell EngineeringCell BiologyNovel TherapyCell-specific Gene Therapy